The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,181,901 in first-year total cost, median $538,265.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-I (M1)]3
- Special Emphasis Panel[ZHL1 CSR-I (M3)]3
Most frequent institutions
- CINCINNATI CHILDRENS HOSP MED CTR1
- CLEVELAND CLINIC LERNER COM-CWRU1
- MAYO CLINIC ROCHESTER1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- UNIVERSITY OF ROCHESTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | TRPV4-PI3K Axis Mediates Pulmonary and Cardiac Fibrosis1R01HL133721-01A1 | OLMAN, MITCHELL ALANPRASAD, SATHYAMANGLA V | CLEVELAND CLINIC LERNER COM-CWRU, OH | $560,000 | ZHL1 |
| 2017 | Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis1R01HL133801-01A1 | CHOI, AUGUSTINE MCHOI, MARY E | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $539,280 | ZHL1 |
| 2017 | Role of pericytes in scleroderma skin and lung fibrosis1R01HL133751-01A1 | FEGHALI-BOSTWICK, CAROL A.SCHNAPP, LYNN M | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $521,185 | ZHL1 |
| 2016 | Targeting matrix stiffness in lung and liver fibrosis1R01HL133320-01 | SHAH, VIJAY H.TSCHUMPERLIN, DANIEL J. | MAYO CLINIC ROCHESTER, MN | $540,586 | ZHL1 |
| 2016 | Dysregulation of common metabolic and transcriptional pathways in heart and lung fibrosis1R01HL133761-01 | PHIPPS, RICHARD P.SMALL, ERIC M | UNIVERSITY OF ROCHESTER, NY | $537,250 | ZHL1 |
| 2016 | Targeting pathologic G-protein signaling in cardiac and kidney fibrosis1R01HL133695-01 | BLAXALL, BURNS CDEVARAJAN, PRASAD | CINCINNATI CHILDRENS HOSP MED CTR, OH | $483,600 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.